Drug recall · January 28, 2015
Virazole recall
Why: Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.
- Lots / codes
Lot #: 340353F, Exp 10/2018
- Quantity
- 2,428 vials
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- Nationwide and Australia
- Initiated
- December 31, 2014 · Voluntary: Firm initiated
- Classified
- January 22, 2015
- Reported
- January 28, 2015
- Ended
- October 4, 2017
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ribavirin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.